Skip to main content
. 2022 Jan 23;11(2):215. doi: 10.3390/antiox11020215

Table 2.

Subject demographic and baseline characteristics.

Demographic Data Baseline 2 g CAW * 4 g CAW *
Gender, % (n)
Female 40% (n = 2) 25% (n = 1) 25% (n = 1)
Male 60% (n = 3) 75% (n = 3) 75% (n = 3)
Age a (year) 70 [59] 67.8 [2.8] 67.8 [2.8]
Body mass index b (kg/m2) 28 ± 2 27 ± 2 27 ± 2
Systolic blood pressure b (mmHg) 132 ± 7 117 ± 5 124 ± 5
Diastolic blood pressure b (mmHg) 81 ± 3 75 ± 3 74 ± 3
Body temperature b (°C) 36.7 ± 0.08 36.6 ± 0.03 36.9 ± 0.08
Heart rate b (bpm) 68 ± 5 69 ± 3 62 ± 5
Race, % (n)
American Indian/Alaska Native 0 0 0
Asian 0 0 0
Black or African American 0 0 0
Native Hawaiian or Other Pacific Islander 0 0 0
White 100 (5) 100 (4) 100 (4)
Clinical laboratory screening b
White blood cell (×103/µL) 7.28 ± 0.60 NM NM
Red blood cell (×106/µL) 4.64 ± 0.21 NM NM
Hemoglobin (g/dL) 14.3 ± 0.6 NM NM
Hematocrit (%) 44 ± 2 NM NM
Platelet (×103/µL) 259 ± 20 NM NM
Blood glucose (mg/dL) 81 ± 3 92 ± 6 89 ± 8
Blood urea nitrogen (mg/dL) 17 ± 3 24 ± 2 ^ 24 ± 3 ^
Creatinine (mg/dL) 0.90 ± 0.06 0.85 ± 0.06 0.83 ± 0.09
Total bilirubin (mg/dL) 0.6 ± 0.1 0.7 ± 0.1 0.8 ± 0.1
Aspartate aminotransferase (U/L) 26 ± 3 28 ± 6 37 ± 2
Alanine aminotransferase (U/L) 32 ± 3 39 ± 6 43 ± 7
Alkaline phosphatase (U/L) 87 ± 12 84 ± 9 80 ± 7
Total Protein (g/dL) 7.7 ± 0.1 7.2 ± 0.2 7.1 ± 0.2
Albumin (g/dL) 3.8 ± 0.1 3.7 ± 0.1 3.6 ± 0.1
Sodium (mmol/L) 141 ± 1 141 ± 1 141 ± 1
Chloride (mmol/L) 108 ± 1 109 ± 0.5^ 110 ± 1 ^
Potassium (mmol/L) 3.8 ± 0.1 3.8 ± 0.2 4.1 ± 0.3
Total CO2 (mmol/L) 29 ± 1 28 ± 0.3 28 ± 1
Calcium (mg/dL) 9.3 ± 0.1 9.1 ± 0.1 9.3 ± 0.9
Anion Gap 5 ± 1 5 ± 1 4 ± 1

a Data are expressed as median [IQR]. b Data are expressed as mean ± SEM, (n = 5 for baseline, n = 4 for 2 g CAW and 4 g CAW). ^ = outside of reference range but deemed not clinically significant. NM = Not measured. * = Data from 10 h time point.